Comparison | Before matching | After matching | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-Value | HR | 95% CI | P-Value | |
Progression-free survival | ||||||
Everolimus vs. Placebo | 0.38 | 0.29-0.49 | <0.001 | 0.35 | 0.24-0.52 | <0.001 |
Sunitinib vs. Placebo | 0.42 | 0.26-0.66 | <0.001 | 0.42 | 0.26-0.66 | <0.001 |
Everolimus vs. Sunitiniba | 0.90 | 0.53-1.53 | 0.695 | 0.84 | 0.46-1.53 | 0.578 |
Overall survival | ||||||
Everolimus vs. Placebo in A6181111 | 0.53 | 0.35-0.78 | 0.002 | 0.61 | 0.38-0.98 | 0.042 |
Everolimus vs. Sunitinib | 0.69 | 0.46-1.05 | 0.087 | 0.81 | 0.49-1.31 | 0.383 |